(SABRE) cohort Therese Tillin Institute of Cardiovascular Science - - PowerPoint PPT Presentation

sabre cohort
SMART_READER_LITE
LIVE PREVIEW

(SABRE) cohort Therese Tillin Institute of Cardiovascular Science - - PowerPoint PPT Presentation

Southall And Brent REvisited (SABRE) cohort Therese Tillin Institute of Cardiovascular Science University College London .and Brent Background- mid 1980s A) Higher rates of diabetes, coronary heart disease and stroke in South Asians B)


slide-1
SLIDE 1

Southall And Brent REvisited (SABRE) cohort

Therese Tillin Institute of Cardiovascular Science University College London

slide-2
SLIDE 2

….and Brent

slide-3
SLIDE 3

Background- mid 1980s

A) Higher rates of diabetes, coronary heart disease and stroke in South Asians B) Higher rates of diabetes, hypertensive organ damage and stroke in African Caribbeans, but less coronary heart disease Why? Insulin resistance, body fat distribution and associated cardiometabolic disturbances?

McKeigue P, Marmot M et al, Lancet 1985 McKeigue P, Marmot M, BMJ, 1988 Wild S, McKeigue P, BMJ, 1997

slide-4
SLIDE 4

Southall and Brent studies baseline methods: 1988-91

  • Population based study: age 40-69, 5000 people
  • Random selection from primary care lists (78%) and local

workplaces

  • 2346 Europeans (76% men).
  • 1710 Indian Asians(83% men), 801 African Caribbeans (57%

men, 92% from Caribbean)- all first generation migrants

  • Baseline (1988-91): fasting bloods, OGTT, anthropometrics, BP,

health and lifestyle questionnaire

Subset (African Caribbeans and Europeans): 24 hour ambulatory blood pressure Echocardiography Retinal photography

slide-5
SLIDE 5

Southall and Brent baseline study findings (Cross-sectional)

South Asians: central obesity, insulin resistant, dyslipidaemic regardless of ethnic sub-group.

slide-6
SLIDE 6

Southall and Brent baseline study findings (Cross-sectional)

South Asians: central obesity, insulin resistant, dyslipidaemic regardless of ethnic sub-group. Is insulin resistance the underlying explanation for excess CVD risk?

slide-7
SLIDE 7

Southall and Brent baseline study findings (Cross-sectional)

African Caribbeans: less central obesity (in men), favourable lipids, but more glucose and less insulin than Europeans. Higher resting BP in African Caribbean women was enough to explain excess stroke, but not in men. More left ventricular structural impairment and adverse remodelling patterns

slide-8
SLIDE 8

Southall and Brent baseline study findings (Cross-sectional)

African Caribbeans: less central obesity (in men), favourable lipids, but more glucose and less insulin than Europeans. Higher resting BP in African Caribbean women was enough to explain excess stroke, but not in men. More left ventricular structural impairment and adverse remodelling patterns Is diabetes is different in African Caribbeans? Does this lead to protection from CHD? Why more stroke? (24 hour BP was not the whole story)

slide-9
SLIDE 9

20 year mortality and morbidity follow-up (V2) Southall and Brent Revisited (SABRE)

  • Why more diabetes in both ethnic minorities?
  • Why more CHD in South Asians?
  • Why more stroke in both ethnic minorities?
  • Subclinical circulatory disease?
  • Risk factor intervention thresholds?
slide-10
SLIDE 10

20 year mortality and morbidity follow-up (V2) Southall and Brent Revisited (SABRE)

  • 2008-2011, age 60-90
  • Mortality/ cancer registration
  • Survivors invited to attend follow-up clinic at St Mary’s Hospital /complete health

and lifestyle questionnaire/ consent to primary care medical record review

slide-11
SLIDE 11

20 year mortality and morbidity follow-up (V2) Southall and Brent Revisited (SABRE)

  • 2008-2011, age 60-90
  • Mortality/ cancer registration
  • Survivors invited to attend follow-up clinic at St Mary’s Hospital /complete health

and lifestyle questionnaire/ consent to primary care medical record review

  • Clinic measurements included:

– Fasting and OGTT bloods – Anthropometrics – CT: coronary calcium and abdominal and mid-thigh fat depots – MRI: brain- white matter hyperintensities, infarcts, hippocampal and brain volumes – Retinal photography – Cognitive function – 2D and 3D echocardiography – Vascular assessment- central, brachial and ankle BP, pulse wave velocity, carotid IMT

slide-12
SLIDE 12

Cumulative incidence of diabetes during 20 years of follow-up

Mean age at diagnosis of incident diabetes: Europeans: 67 years South Asians: 62 years African Caribbeans: 68 years

Tillin T, Hughes AD, Godsland IF, Whincup P, Forouhi N, Welsh P, Sattar N, McKeigue PM, Chaturvedi N, Diabetes Care 2013

.1 .2 .3 .4 .5 .6 Cumulative Incidence 40 50 60 70 80 90 Age European South Asian African Caribbean

  • a. MEN

.1 .2 .3 .4 .5 .6 Cumulative Incidence 40 50 60 70 80 90 Age European South Asian African Caribbean

  • b. WOMEN
slide-13
SLIDE 13

20 60 40 20 21 22 23 24 25 26 27 28 29 30 31 Body mass index, kg/m2 European South Asian African Caribbean

Incidence of diabetes over 20 years of follow-up and baseline BMI, age adjusted

slide-14
SLIDE 14

20 60 40 20 21 22 23 24 25 26 27 28 29 30 31 Body mass index, kg/m2 European South Asian African Caribbean

Incidence of diabetes over 20 years of follow-up and baseline BMI, age adjusted

slide-15
SLIDE 15

CHD and stroke incidence: fatal and non-fatal first events, age and sex adjusted

.2 .4 .6 .8 40 50 60 70 80 90 Age Europeans South Asians African Caribbeans

Coronary heart disease incidence

.1 .2 .3 .8 40 50 60 70 80 90 Age Europeans South Asians African Caribbeans

Stroke incidence

slide-16
SLIDE 16

5 10 15 20 25

European men South Asian men African Caribbean men European women South Asian women African Caribbean women

% risk (95% CI)

Observed events QRISK2 predicted Framingham predicted

Predicting CVD risk over 10 years of follow-up: QRISK2 and Framingham

Tillin T, Hughes AD, Whincup P, Mayet J, Sattar N, McKeigue PM, Chaturvedi N, , Heart Jan 2014

slide-17
SLIDE 17

Proportion of observed events which occurred in participants identified as high risk (>20%) by Framingham and QRISK2

% of events predicted by QRISK2>=20% % of events predicted by Framingham >=20%

10 20 30 40 50 60 70

European men South Asian men African Caribbean men European women South Asian women African Caribbean women

%

slide-18
SLIDE 18

CHD and stroke incidence: fatal and non-fatal first events

Tillin T, Hughes AD, Mayet J, Whincup P, Forouhi N, Sattar N, McKeigue PM, Chaturvedi N, JACC 2013

slide-19
SLIDE 19

CHD and stroke incidence: fatal and non-fatal first events

Tillin T, Hughes AD, Mayet J, Whincup P, Forouhi N, Sattar N, McKeigue PM, Chaturvedi N, JACC 2013 P for ethnicity x diabetes interactions for stroke: South Asians vs Europeans: 0.038 African Caribbeans vs Europeans: 0.019

slide-20
SLIDE 20

SABRE V2: White matter hyperintensities (severe: 3+) and large infarcts in Europeans and African Caribbeans

Shibata D, Tillin T, Beauchamp N, Heasman J, Hughes AD, Park C, Gedroyc W, Chaturvedi N, J Hypertens, 2013

Brain Infarcts Severe White Matter Hyperintensities

slide-21
SLIDE 21

European South Asian African Caribbean Global cognitive function (average z score) 0.31± 0.62

  • 0.23 ± 0.53**
  • 0.25 ± 0.58**

Diabetes vs no diabetes Odds ratio for lowest 10% of cognitive function score 1.20(0.66, 2.18) 1.86(1.09, 3.17) 2.80(1.24, 6.32) † Hippocampal volume (mm) 7.60±0.04 7.06±0.05** 7.29±0.07** Diabetes vs no diabetes Odds ratio for lowest 10% of hippocampal volume 0.58(0.26, 1.29) 2.47(1.18, 5.18)** § 1.64(0.63, 4.27) ††

Ethnic differences in cognitive impairment and hippocampal volumes in SABRE 20 year follow-up (mean ±SE)

Data are adjusted for age, sex and educational status. *p<0.05 Europeans as comparator **p<0.01 Europeans as comparator

§ p<=0.01 for ethnicity x diabetes interaction

†p=0.058 for ethnicity x diabetes interaction ††p=0.093 for ethnicity x diabetes interaction

slide-22
SLIDE 22

European South Asian African Caribbean Global cognitive function (average z score) 0.31± 0.62

  • 0.23 ± 0.53**
  • 0.25 ± 0.58**

Diabetes vs no diabetes Odds ratio for lowest 10% of cognitive function score 1.20(0.66, 2.18) 1.86(1.09, 3.17) 2.80(1.24, 6.32) † Hippocampal volume (mm) 7.60±0.04 7.06±0.05** 7.29±0.07** Diabetes vs no diabetes Odds ratio for lowest 10% of hippocampal volume 0.58(0.26, 1.29) 2.47(1.18, 5.18)** § 1.64(0.63, 4.27) ††

Ethnic differences in cognitive impairment and hippocampal volumes in SABRE 20 year follow-up (mean ±SE)

Data are adjusted for age, sex and educational status. *p<0.05 Europeans as comparator **p<0.01 Europeans as comparator

§ p<=0.01 for ethnicity x diabetes interaction

†p=0.058 for ethnicity x diabetes interaction ††p=0.093 for ethnicity x diabetes interaction

slide-23
SLIDE 23

European South Asian African Caribbean Global cognitive function (average z score) 0.31± 0.62

  • 0.23 ± 0.53**
  • 0.25 ± 0.58**

Diabetes vs no diabetes Odds ratio for lowest 10% of cognitive function score 1.20(0.66, 2.18) 1.86(1.09, 3.17) 2.80(1.24, 6.32) † Hippocampal volume (mm) 7.60±0.04 7.06±0.05** 7.29±0.07** Diabetes vs no diabetes Odds ratio for lowest 10% of hippocampal volume 0.58(0.26, 1.29) 2.47(1.18, 5.18)** § 1.64(0.63, 4.27) ††

Ethnic differences in cognitive impairment and hippocampal volumes in SABRE 20 year follow-up (mean ±SE)

Data are adjusted for age, sex and educational status. *p<0.05 Europeans as comparator **p<0.01 Europeans as comparator

§ p<=0.01 for ethnicity x diabetes interaction

†p=0.058 for ethnicity x diabetes interaction ††p=0.093 for ethnicity x diabetes interaction

slide-24
SLIDE 24

European South Asian African Caribbean Global cognitive function (average z score) 0.31± 0.62

  • 0.23 ± 0.53**
  • 0.25 ± 0.58**

Diabetes vs no diabetes Odds ratio for lowest 10% of cognitive function score 1.20(0.66, 2.18) 1.86(1.09, 3.17) 2.80(1.24, 6.32) † Hippocampal volume (mm) 7.60±0.04 7.06±0.05** 7.29±0.07** Diabetes vs no diabetes Odds ratio for lowest 10% of hippocampal volume 0.58(0.26, 1.29) 2.47(1.18, 5.18)** § 1.64(0.63, 4.27) ††

Ethnic differences in cognitive impairment and hippocampal volumes in SABRE 20 year follow-up (mean ±SE)

Data are adjusted for age, sex and educational status. *p<0.05 Europeans as comparator **p<0.01 Europeans as comparator

§ p<=0.01 for ethnicity x diabetes interaction

†p=0.058 for ethnicity x diabetes interaction ††p=0.093 for ethnicity x diabetes interaction

slide-25
SLIDE 25

SABRE V2:Toxic diabetes and left ventricular function?

Peak velocity during systole

Ratio of early filling and early myocardial velocity=E/e′ (index of LV filling pressure) NT-pro BNP= marker of global dysfunction

Park C, Marsh K, Ghosh A et al, Diabetes Care 2014, in press

South Asians Europeans

slide-26
SLIDE 26

SABRE V2:Toxic diabetes and left ventricular function?

Peak velocity during systole

Ratio of early filling and early myocardial velocity=E/e′ (index of LV filling pressure) NT-pro BNP= marker of global dysfunction

Park C, Marsh K, Ghosh A et al, Diabetes Care 2014, in press

Europeans South Asians

slide-27
SLIDE 27

Arterial stiffness and elastance, by HbA1c

Park C, Tillin T, March K, Jones S, Whincup P, Mayet J, Chaturvedi N, Hughes AD, under review

slide-28
SLIDE 28

What about sex?

CHD incidence rates/1000 person years

10 20 30 40 50 60 56-70 years 70+ years

slide-29
SLIDE 29

Summary from SABRE 20 year follow-up

  • Incidence of diabetes in South Asians and African Caribbeans ++ even in older age
  • South Asians and African Caribbeans are at increased risk of diabetes at lower

levels of obesity

  • CHD incidence ++ in South Asians and - - in African Caribbeans
  • South Asian women CHD incidence= European men
  • ?Diabetes toxicity in South Asians and African Caribbeans: stroke, cognitive

function, hippocampal volume, WMH/brain infarcts, LV function, arterial stiffness and load

  • Risk scores such as Framingham and QRISK2 may not serve ethnic minorities so

well

slide-30
SLIDE 30

SABRE V3: 25 years of follow-up 2014-2017

Ages 65-91 (mean age: 75) index participants and partners. Focus on ethnic and sex differences in diabetes and function: cardiovascular , cognitive, physical .

slide-31
SLIDE 31

Thank you to the SABRE Study group and to all participants

The SABRE Study group: Nish Chaturvedi (University College London) (Principal Investigator) Mark Baker (Imperial College London) Carol Brayne (University of Cambridge) Norman Beauchamp (University of Washington, Seattle) Emma Coady (University College London) Rory Collins (University of Oxford) Nita Forouhi (Medical Research Council Epidemiology Unit, Cambridge) Darrel Francis (Imperial College London) Wladyslaw Gedroyc (Imperial College London) Ian Godsland (Imperial College London) Rebecca Hardy (University College London) Andrew Hattersley (Peninsula Medical School, University of Exeter) John Heasman (Imperial College London) Alun Hughes (University College London) Siana Jones (Imperial College London) Daniel Key (University College London) Azeem Majeed (Imperial College London) Katherine March (University College London) Jamil Mayet (Imperial College London) April McGowan (Imperial College London) Paul McKeigue (University of Edinburgh) Chloe Park (University College London) Martin Prince (Kings College London) Marcus Richards (MRC) Naveed Sattar (University of Glasgow) Dean Shibata (University of Washington, Seattle) Robert Stewart (Kings College London) Therese Tillin (University College London) Claire Tuson (Imperial College London) Helen Walkey (Imperial College London) Joe Willis (Imperial College London) Sumangali Wijetunge (Imperial College London) Peter Whincup (St George’s, University of London) Andrew Wright (Imperial College London)